Paradoxical Pandora's box of pigmentary side effects by imatinib mesylate in case of chronic myeloid leukemia

被引：0
|
作者：
Pardeshi, Snehal S. [1 ]
Havanur, Preeti [1 ]
Kharkar, Vidya [1 ]
Mahajan, Sunanda [1 ]
Khopkar, Uday [1 ]
机构：
[1] Seth GSMC & KEM Hosp, Mumbai, Maharashtra, India
来源：
DERMATOLOGIC THERAPY | 2022年 / 35卷 / 05期
关键词：
D O I：
10.1111/dth.15402
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Imatinib Mesylate in Newly Diagnosed Patients of Chronic Myeloid Leukemia
    Jacob, L. Abraham
    Bapsy, P. P.
    Babu, K. Govind
    Lokanatha
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 20 - 25
  • [22] Hypophosphatemia observed in chronic myeloid leukemia patients treated with imatinib mesylate (Gleevec®) is related to digestive side-effects.
    Legros, Laurence
    Breuil, Veronique
    Ferrari, Patricia
    Testa, Jean
    Cassuto, Jill-Patrice
    BLOOD, 2006, 108 (11) : 274B - 274B
  • [23] Low dose Dasatinib in refractory Imatinib mesylate chronic myeloid leukemia: Case report
    Radaelli, F.
    Reda, G.
    Ripamonti, F.
    Gardellini, A.
    Vener, C.
    Lambertenghi Deliliers, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 183 - 184
  • [24] Ocular side effects in chronic myeloid leukemia patients treated with imatinib
    Breccia, Massimo
    Gentilini, Fabiana
    Cannella, Laura
    Latagliata, Roberto
    Carmosino, Ida
    Frustaci, Annamaria
    Alimena, Giuliana
    LEUKEMIA RESEARCH, 2008, 32 (07) : 1022 - 1025
  • [25] Ocular side effects in chronic myeloid leukemia patients treated with Imatinib
    Breccia, M.
    Latagliata, R.
    Carmosino, I
    Cannella, L.
    Levi, A.
    Frustaci, A.
    Stefanizzi, C.
    Volpicelli, P.
    Alimena, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 183 - 183
  • [26] Compliance with taking imatinib mesylate in patients with chronic myeloid leukemia in the chronic phase
    Kiguchi, Toru
    Tauchi, Tetsuzo
    Ito, Yoshikazu
    Miyazawa, Keisuke
    Kimura, Yukihiko
    Ohyashiki, Kazuma
    LEUKEMIA RESEARCH, 2009, 33 (03) : 506 - 508
  • [27] Imatinib mesylate in chronic myeloid leukemia of childhood: From care to cure?
    Warrier, Arun
    Santa, Ayyagari
    Sagar, T. G.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 577 - 577
  • [28] Imatinib mesylate can induce molecular remissions in chronic myeloid leukemia
    Lawler, M
    Gately, K
    Ryan, J
    Carroll, P
    Howard, J
    Stallings, R
    Conneally, E
    McCann, S
    BONE MARROW TRANSPLANTATION, 2003, 31 : S160 - S160
  • [29] Drug Efflux Transporters and Imatinib Mesylate Insensitivity in Chronic Myeloid Leukemia
    Aquino Moreira-Nunes, Caroline Fatima
    Simoes Beltrao, Ana Cristina
    Valente Martins Frances, Larissa Tatiana
    Mattos Amaral Sousa, Rodrigo Guarischi
    Silva, Israel Tojal
    Silva, Artur Luiz
    Silva-, Wilson Araujo, Jr.
    Rodrigues Lemos, Jose Alexandre
    BLOOD, 2012, 120 (21)
  • [30] IMATINIB MESYLATE INDUCED HEPATOTOXICITY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML)
    Milosevic, V.
    Bogdanovic, A.
    Djordjevic, V.
    Fekete, M. Dencic
    Mihaljevic, B.
    Gotic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 545 - 546
12345